Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Potential clinical and economic impact of switching branded medications to generics

  • In: Posters
  • At: Dublin (Ireland) (2013)
  • Type: Poster
  • By: LIU, Larry (Pfizer Inc., New York, United States of America)
  • Co-author(s): Straka, Robert (University of Minnesota College of Pharmacy, Minneapolis, United States of America)
    Keohane, Denis (Pfizer Inc., New York, United States of America)
    Liu, Larry (Pfizer Inc., New York, United States of America)
  • Abstract:

    Background information: Switching branded medications to generics is a common cost-containment practice. Although an important objective for healthcare sustainability, studies of the impact of this practice on patient outcomes are warranted.

    Setting: Literature review summarizing the potential clinical and economic impact of switching branded..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses